Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB235860

SARS-CoV-2 Omicron (XBB.1) Spike Antibody (D007), Alexa Fluor™ 647 , Novus Biologicals™
SDP

Catalog No. NB235860 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB235860 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB235860 Supplier Novus Biologicals Supplier No. NBP318852AF647
Only null left
Add to Cart
Add to Cart

Description

Human Monoclonal Antibody

SARS-CoV-2 Omicron (XBB.1) Spike Monoclonal antibody specifically detects SARS-CoV-2 Omicron (XBB.1) Spike in SARS-CoV-2 samples. It is validated for ELISA

Specifications

Antigen SARS-CoV-2 Omicron (XBB.1) Spike
Applications ELISA
Classification Monoclonal
Clone D007
Conjugate Alexa Fluor 647
Formulation 50mM Sodium Borate
Host Species Human
Immunogen This is a chimeric monoclonal antibody combining the constant domains of the human IgG1 molecule with mouse variable regions. The variable region was obtained from a mouse immunized with purified, recombinant SARS-CoV-2 Omicron (XBB.1) Spike Protein. The antibody was produced using recombinant antibody technology.
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Target Species SARS-CoV-2
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.